Stocks · Health care · Biological Products, (No Diagnostic Substances)

ADMA BIOLOGICS, INC.

ADMA Clue Score77
United States Fiscal year ends December CIK 0001368514 Results filed 4 Nov 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Adam S Grossman
5 Nov 2026
President and CEO
Sold after exercise
42,000
$12.00
$504.00K
Adam S Grossman
5 Nov 2026
President and CEO
Sold after exercise
105,000
$12.00
$1.26M
Jerrold B Grossman
27 May 2026
Director
Buy
6,400
$7.91
$50.62K
Jerrold B Grossman
12 May 2026
Director
Buy
12,500
$8.01
$100.13K
Jerrold B Grossman
11 May 2026
Director
Buy
12,500
$8.01
$100.13K
Adam S Grossman
16 Mar 2026
President and CEO
Sold after exercise
6,000
$15.16
$90.96K
Adam S Grossman
16 Mar 2026
President and CEO
Sold after exercise
15,000
$15.16
$227.40K
Lawrence P. Guiheen
13 Mar 2026
Director
Exercised, kept
30,000
$3.66
$109.80K
Kaitlin M. Kestenberg-Messina
9 Mar 2026
COO and SVP, Compliance
Sold after exercise
10,096
$15.63
$157.80K
Steve Elms
6 Mar 2026
Director
Buy indirect
7,000
$15.39
$107.73K
Steve Elms
5 Mar 2026
Director
Buy indirect
7,000
$15.67
$109.69K
Adam S Grossman
17 Feb 2026
President and CEO
Sold after exercise
6,000
$16.08
$96.48K
Adam S Grossman
17 Feb 2026
President and CEO
Sold after exercise
15,000
$16.08
$241.20K
Adam S Grossman
15 Dec 2025
President and CEO
Sold after exercise
6,000
$19.79
$118.74K
Adam S Grossman
15 Dec 2025
President and CEO
Sold after exercise
15,000
$19.79
$296.85K
Adam S Grossman
19 Nov 2025
President and CEO
Sold after exercise
6,000
$16.00
$96.00K
Adam S Grossman
19 Nov 2025
President and CEO
Sold after exercise
15,000
$16.00
$240.00K

What was left out

Form 4 filings counted 27
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 11
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 1,097,867
History held since 13 Feb 2012